Uri Danon

Title: Innovations by Uri Danon in Multiple Sclerosis Treatment

Introduction

Uri Danon is an accomplished inventor based in Tel Aviv, Israel. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis (MS). With a total of three patents to his name, Danon's work focuses on innovative depot formulations that aim to improve patient outcomes.

Latest Patents

Danon's latest patents include a depot system comprising glatiramer acetate. This invention provides compositions and methods for treating or ameliorating multiple sclerosis by administering a depot formulation containing 40 mg of glatiramer acetate intramuscularly to MS patients. Another notable patent is a method for suppressing or alleviating primary or secondary progressive multiple sclerosis using a sustained release depot formulation comprising glatiramer acetate. This invention outlines methods for treating primary progressive multiple sclerosis (PPMS) or secondary progressive multiple sclerosis (SPMS) and related symptoms through the administration or implantation of a depot formulation containing glatiramer salts.

Career Highlights

Uri Danon is associated with Mapi Pharma Ltd., where he continues to develop innovative solutions for MS treatment. His work has garnered attention for its potential to enhance the quality of life for patients suffering from this debilitating condition.

Collaborations

Danon collaborates with notable colleagues, including Nadav Bleich Kimelman and Ehud Marom. Their combined expertise contributes to the advancement of research and development in the field of multiple sclerosis.

Conclusion

Uri Danon's innovative contributions to the treatment of multiple sclerosis through his patented formulations highlight his commitment to improving patient care. His work exemplifies the impact of dedicated inventors in the medical field.